Skip to main content
. 2019 Dec 19;10:1427. doi: 10.3389/fphar.2019.01427

Figure 9.

Figure 9

The possible mechanism by which Bavachin protects HASMCs against β-glycerophosphate-mediated VC and apoptosis, occurs via the activation of mTOR-dependent autophagy and suppression of β-catenin signalling.